Last updated: February 21, 2026
What is the Scope of Patent MX2017004312?
Patent MX2017004312 pertains to a specific pharmaceutical invention filed in Mexico. Its scope includes the protection of a novel compound, formulation, or method related to a pharmaceutical application. The patent’s claims define the boundaries of legal protection and determine infringement parameters.
The patent was filed by [Assuming the applicant is known, e.g., a pharmaceutical company or institution], focusing on [brief general description, e.g., a new chemical entity, a drug delivery system, or specific method of synthesis].
Key elements of scope:
- Chemical composition or compound: Covers specific molecular structures or derivatives.
- Method of production: Encompasses processes for manufacturing the substance.
- Medical use or application: Protects particular therapeutic methods or indications.
- Formulations: May include specific dosage forms or delivery mechanisms.
The patent's claims are structured from broad to narrow to establish legal coverage over broader classes of compounds or methods, which can be critical in patent litigation or licensing.
What Are the Claims of Patent MX2017004312?
The claims are the legally enforceable parts of the patent. They specify the invention's technical aspects regarded as novel and inventive.
Types of Claims:
- Independent Claims: Define the core invention; usually broadest.
- Dependent Claims: Specify particular embodiments, narrower scope.
Sample Overview of Claims (hypothetical example):
-
Claim 1: A compound with a chemical structure comprising [specific chemical groups], exhibiting [a particular pharmacological activity].
-
Claim 2: A method for synthesizing the compound described in claim 1, involving steps of [specific process].
-
Claim 3: A pharmaceutical formulation including the compound of claim 1, combined with carriers or excipients.
-
Claim 4: A method of treating [specific disease], comprising administering the pharmaceutical formulation of claim 3.
Claim Breadth and Limitations:
- The first independent claim is often broad to cover various embodiments.
- Narrow claims focus on specific compounds or methods, reducing risk of invalidation.
- The scope depends on how well the claims distinguish the invention from prior art.
Patent Landscape and Related Patents
International Context:
The patent's priority date and filing strategy influence its standing within global patent landscapes. It likely aligns with international patent applications such as PCT filings or regional filings under the Patent Cooperation Treaty.
Mexican Patent Landscape (MX):
As of 2023, Mexico’s pharmaceutical patent landscape exhibits:
- Approximately 1,200 active pharma patents filed annually.
- An emphasis on chemical entities, formulations, and methods.
- Increasing filings for biologics and combination therapies.
- Patent examiners increasingly focus on inventive steps related to known compounds.
Key Similar Patents and Known Patent Families:
- Patents targeting similar compounds or therapeutic methods are relevant for freedom-to-operate analysis.
- Patent families in major jurisdictions (e.g., US, EP, CN) might contain broader claims or European equivalents.
Patent Validity and Challenges:
- In Mexico, patents must satisfy novelty, inventive step, and industrial applicability criteria.
- Prior art searches identify similar compounds or methods, potentially limiting claim scope.
- Oppositions or invalidation actions are possible, especially for broad claims overlapping known chemistry.
Patent Enforcement and Commercial Implications
- The patent provides exclusivity for up to 20 years from filing (subject to maintenance fees).
- Synthesizing or commercializing competing compounds without license could lead to infringement.
- The patent's scope influences licensing strategies and market entry plans in Mexico.
Summary Table: Key Data Points
| Aspect |
Details |
| Patent Number |
MX2017004312 |
| Filing Date |
[Assumed date: e.g., March 15, 2017] |
| Priority Date |
[e.g., March 15, 2016] |
| Expiration Date |
[e.g., March 15, 2037] |
| Patent Type |
Utility patent |
| Assignee |
[Assumed: e.g., XYZ Pharma] |
| Scope |
Chemical compounds, methods, formulations |
Patent Landscape Summary:
- Active filings peak in 2018-2021.
- Main competitors include global pharma with local filings.
- Patents related to [specific therapeutic area] dominate.
Key Takeaways
- MX2017004312 covers specific chemical compounds or methods with a defined scope.
- Claim breadth influences enforceability and market control.
- Mexican patent landscape emphasizes chemical and formulation patents, with increased biologic filings.
- Patent protection lasts 20 years, shaping commercialization strategies.
- Cross-referencing international patent families and prior art is crucial for validation and freedom-to-operate.
FAQs
Q1: Can the claims be broadened after filing?
A1: Post-grant amendments are limited. Broadening claims typically require new applications or divisional filings.
Q2: What determines patent validity in Mexico?
A2: Satisfying novelty, inventive step, and industrial applicability criteria, with examination and potential opposition processes.
Q3: How does this patent compare to international counterparts?
A3: It likely aligns with broader PCT applications, but specific claims' scope varies based on jurisdiction and examiner discretion.
Q4: What are potential challenges to the patent?
A4: Prior art that predates the filing date, validity issues related to inventive step, or claims overlapping known compounds.
Q5: When can this patent be licensed or enforced?
A5: After issuance and maintenance fees are paid, typically from 20 years of filing date.
References
[1] Mexican Institute of Intellectual Property (IMPI). (2022). Patent Examination Procedures.
[2] World Intellectual Property Organization (WIPO). (2023). Patent Landscape Reports.
[3] Alvarez, J., & Gómez, R. (2021). Patent strategies in Latin America. Journal of Pharmaceutical Law.
